Inactive Instrument

News Progenics Pharmaceuticals, Inc.

Stocks

US7431871067

Biotechnology & Medical Research

All News

22/06/20	PROGENICS PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
22/06/20	Progenics Pharmaceuticals, Inc. Announces Board Changes	CI
22/06/20	Progenics Pharmaceuticals, Inc. Announces Executive Changes	CI
22/06/20	Progenics Pharmaceuticals, Inc. Announces Executive Changes	CI
22/06/20	Progenics Pharmaceuticals, Inc. Appoints Robert J. Marshall Jr. as Treasurer	CI
22/06/20	Progenics Pharmaceuticals : Lantheus Completes Merger with Progenics	BU
22/06/20	Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P Composite 1500	CI
22/06/20	Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P 600	CI
22/06/20	Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P 1000	CI
22/06/20	Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P TMI Index	CI
22/06/20	Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P Global BMI Index	CI
22/06/20	Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P 600 Health Care	CI
22/06/20	Progenics Pharmaceuticals, Inc.(NasdaqGS:PGNX) dropped from S&P Biotechnology Select Industry Index	CI
17/06/20	PROGENICS PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
16/06/20	PROGENICS PHARMACEUTICALS INC : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
16/06/20	Progenics Stockholders Approve Merger with Lantheus	GL
11/06/20	PROGENICS PHARMACEUTICALS INC : Change in Directors or Principal Officers (form 8-K)	AQ
08/06/20	PROGENICS PHARMACEUTICALS INC : Other Events (form 8-K)	AQ
28/05/20	PROGENICS PHARMACEUTICALS INC : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)	AQ
19/05/20	Progenics Pharmaceuticals : to Present Results from the Phase 3 CONDOR Trial of PyL in Prostate Cancer at the American Society of Clinical Oncology 2020 Virtual Scientific Program	AQ
18/05/20	PROGENICS PHARMACEUTICALS INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
18/05/20	Progenics to Present Results from the Phase 3 CONDOR Trial of PyL™ (18F-DCFPyL) in Prostate Cancer at the American Society of Clinical Oncology 2020 Virtual Scientific Program	GL
18/05/20	Progenics Pharmaceuticals, Inc. Announces Results from the Phase 3 Condor Trial of Pyl™	CI
07/05/20	PROGENICS PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
07/05/20	Progenics Pharmaceuticals, Inc., Q1 2020 Earnings Call, May 07, 2020